Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025. The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.
UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077. For SDU business hours, click here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 20, 2013

Drug Name	Review Type	Class	Manufacturer
Quillivant XR	New Drug Initial Review	Stimulants/ADHD	Pfizer
Xeljanz	New Drug Initial Review	Rheumatoid Arthritis	Pfizer
Aubagio	New Drug Initial Review	Multiple Sclerosis	Genzyme
Eliquis	New Drug Initial Review	Oral Anticoagulant	Bristol Myers-Squibb
Sklice	New Drug Initial Review	Pediculicide	Sanofi Pasteur
Gattex	New Drug Initial Review	GLP-2	NPS Pharmaceuticals
Oxtellar XR	New Drug Initial Review	Anticonvulsant	Supernus Pharmaceuticals
Tudorza Pressair	New Drug Initial Review	Long-acting Anticholingeric	Forest
Natroba	New Drug Appeal	Pediculicide	ParaPRO
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	AstraZeneca
Latuda	PDL Appeal	Atypical Antipsychotic	Sunovion

Footer